Jacobs Levy Equity Management, Inc Care Dx, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q3 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 704,080 shares of CDNA stock, worth $11.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
704,080
Previous 1,092,401
35.55%
Holding current value
$11.2 Million
Previous $21.3 Million
52.04%
% of portfolio
0.04%
Previous 0.09%
Shares
10 transactions
Others Institutions Holding CDNA
# of Institutions
200Shares Held
54.5MCall Options Held
150KPut Options Held
57.6K-
Black Rock Inc. New York, NY5.29MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.75MShares$59.8 Million0.0% of portfolio
-
Bamco Inc New York, NY3.16MShares$50.3 Million0.13% of portfolio
-
State Street Corp Boston, MA2.57MShares$40.9 Million0.0% of portfolio
-
Ophir Asset Management Pty LTD2.2MShares$35 Million4.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $852M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...